Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.
Galena Biopharma Inc. (NASDAQ: GALE) shares spiked 8.63 percent to close at $2.14 a share Wednesday. The stock traded between $2.05 and $2.23 on volume of 1.33 million shares traded. The company announced that the European Patent Office has notified them of an intention to grant a Pharmaceutical Use Patent for NeuVax. Shares of Galena Biopharma have gained approximately 40.0 percent year-to-date.
Get more information on Galena Biopharma and free access to the in-depth equity report at:
Incyte Corporation (NASDAQ: INCY) shares soared 33.48 percent to close at $36.04 a share Wednesday. The stock traded between $32.95 and $37.46 on volume of 18.21 million shares traded. The company reported positive results from a Phase II proof-of-concept trial of Ruxolitinib, an experimental pancreatic cancer treatment. Shares of Incyte have fallen approximately 116.0 percent year-to-date.
Get more information on Incyte and free access to the in-depth equity report at:
Inovio Pharmaceuticals Inc. (NYSEMKT: INO) shares surged 32.28 percent to close at $1.68 a share Wednesday. The stock traded between $1.26 and $1.70 on volume of 16.89 million shares traded. The company last week announced its malaria DNA vaccine demonstrated robust immune responses in animal models. Shares of Inovio Pharmaceuticals have gained approximately 25.0 percent year-to-date.
Get more information on Inovio Pharmaceuticals and free access to the in-depth equity report at:
OfficeMax Inc. (NYSE: OMX) shares declined 2.01 percent to close at $10.72 a share Wednesday The stock traded between $10.15 and $10.78 on volume of 2.77 million shares traded. Office retailers were dragged down by Staples’ disappointing quarterly results. Shares of OfficeMax have gained approximately 10.0 percent year-to-date.
Get more information on OfficeMax and free access to the in-depth equity report at:
Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.
Five Star Equities
Leave a comment...